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Bambusae caulis in Liquamen (BCL), traditional herbal medicine used in East Asia, is known to have antioxidative and immune-
regulating properties. We hypothesized that the potential antioxidant eﬀects of BCL might suppress the production of thymus
and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) in human keratinocytes (HaCaT cell).
The immune-regulating eﬀect of BCL was demonstrated by antioxidant capacity using DPPH analysis and DCFH-DA analysis.
We found that BCL had strong ROS scavenge eﬀect in HaCaT cell. BCL also showed suppression of IFN-γ-induced expression of
TARCandMDC,activationofNF-κB,and,moreover,signiﬁcantblockofIFN-γ-induceddegradationandphosphorylationofIκB.
However, it had no eﬀects on phosphorylation of p38 MAPK. Collectively, these results suggest that BCL may have a therapeutic
potential on skin disease such as atopic dermatitis by inhibiting Th2 chemokines which is due, at least in part, to its antioxidant
capacities.
1.Introduction
Chemokines are a superfamily of small cytokines that regu-
late traﬃcking of various types of leukocytes [1]. According
to the position of the ﬁrst two of the four conserved cysteine
residues,chemokinesaredividedintofoursubgroups:CC,C,
CXC,andCX3C[2].Chemokinesbindtoleukocytesviatheir
corresponding seven transmembrane-spanning, G-protein
coupled receptors that have been grouped according to the
structure of their chemokine ligands (CCR, CR, CXCR, and
CX3CR) [3].
Thymus and activation-regulated chemokine (TARC/
CCL17) are a CC chemokine constitutively expressed in a
thymus and is produced by monocyte-derived dendritic cells
[4] and keratinocytes [5]. It is a ligand for CCR4, which
is preferentially expressed on Th2 lymphocytes [6]. Macro-
phage-derived chemokine (MDC/CCL22), a CC chemokine
closely related to TARC, is also speciﬁc ligand for CCR4.
MDC is constitutively produced by dendritic cells, B cells,
macrophages, keratinocytes, and epithelial cells [7–9]. TARC
and MDC are thought to play an important role in the
development of some skin disease such as AD. Previous re-
searchers have reported that the serum levels of TARC
and MDC are signiﬁcantly elevated and correlated with the
disease severity in patients with AD [10]. In addition, the
expressions of TARC [11]a n dM D C[ 5] were signiﬁcantly
increased in the basal epidermis of lesional skin compared
with the healthy controls. Taken together, TARC and MDC
may be involved in the pathogenesis of AD.2 Evidence-Based Complementary and Alternative Medicine
So far, herbal medicines such as Rumex japonicus [12]
and Scutellaria baicalensis [13] are used to treat atopic der-
matitis in Eastern countries. Bambusae caulis in Liquamen
(BCL), the nutritious liquid that is extracted from heat-
treated fresh bamboo stems, is a traditional herbal medicine
widely used in Eastern counties for treatment of coughs
and asthma. In recent years, it was studied for its anti-inf-
lammatory, antiallergenic, immune-regulating, and antiox-
idative capacities [14, 15]. Moreover, the liquid diluted with
water is gaining widespread popularity in Japan as a folk
medicine for skin diseases such as scabies, eczema, and
atopic dermatitis [16]. Recently, our study has demonstrated
that BCL eﬀectively suppresses the development of 2,4-
dinitrochlorobenzene- (DNCB-)induced AD-like skin le-
sions in hairless mice. Of note, BCL has been shown to
regulate the expression of Th2 cytokines such as IL-4 and
IL-13 in hairless mice spleen [17]. Furthermore, intracellular
reactive oxygen species (ROS) contribute to the production
of TARC and MDC in keratinocytes [18]. However, the
eﬀects of BCL on the expression of Th2 chemokines in kera-
tinocytes and the potential mechanism have not been evalu-
ated.
In the present study, we demonstrated that BCL sup-
presses the expression of TARC and MDC, at least in part, by
inhibiting the activation of ROS/IkB/NF-κB signaling path-
ways independent of p38 MAPK pathway in IFN-γ-treat-
ed HaCaT cells.
2.MaterialsandMethods
2.1. Reagents. Bambusae caulis in Liquamen (BCL) was used
as described previously [17]. Bay11-7082 and SB203580
ware purchased from Calbiochem (La Jolla, Calif, USA).
Hydrogenperoxide (H2O2), N-acetyl-Leu-Leu-norleucinal
(ALLN), 4 ,6-Diamidino-2-phenylindole (DAPI), 2,2-di-
phenyl-1-picrylhydrazyl (DPPH), and 2 ,7 -dichlorodi-
hydroﬂuorescin diacetate (DCFH-DA) were purchased from
Sigma-Aldrich Co. (St. Louis, Mo, USA). Recombinant
human interferon (IFN)-γ was purchased from Abcam
(Cambridge, UK). Human TARC/CCL17 and MDC/CCL22
immunoassay kit were purchased from R & D Systems
(Minneapolis, Minn, USA). Antibodies against phospho-
p38 MAPK, p38 MAPK, NF-κB p65, IκB-α, phosphor-IκB-α,
poly(ADP-ribose) polymerase (PARP), β-actin, horseradish
peroxidase- (HRP-)conjugated goat anti-rabbit IgG, and
Alexa Fluor 488 goat antirabbit IgG (H+L) were purchased
from Cell Signaling Technology (Beverly, Mass, USA).
An ECL (enhanced chemiluminescence) Western blotting
detection system was obtained from Amersham Pharmacia
Biotech (Tokyo, Japan).
2.2. Cell Culture. The human keratinocyte cell line, HaCaT
cell, was cultured with RPMI 1640 (BioWhittaker Inc.,
Walkersville, Md, USA) supplemented with 10% fetal bovine
serum (FBS) (BioWhittaker Inc., Walkersville, Md, USA),
1% penicillin/streptomycin (BioWhittaker Inc., Walkersville,
Md, USA) at 37◦Cina5%CO 2 incubator.Beforeperforming
experiments described below, the growth medium was
exchanged for serum-free RPMI 1640 medium.
2.3. Cell Viability Assay. Cell viability was assessed by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) assay according to the method described
previously [19] with some modiﬁcations. Brieﬂy, HaCaT
cells were seeded into 96-well microtiter plates at a density
of 1 × 104 cells/well (200μL) and incubated in complete
medium. After 24h, the medium was replaced with serum-
freemedium containing variousconcentrationsof BCL, with
RPMI 1640 as the negative control. After incubating for
2 4h ,c e l l sw e r et r e a t e dw i t hM T T( 5 0μg/mL) for 4h. The
formazanprecipitatewasdissolvedin200μLofdimethylsul-
foxide (DMSO), and the absorbance at 570nm was detected
with an automated microplate reader. The percentage of
cell viability was calculated by the following formula: cell
viability (%) = (mean absorbency in test wells)/(mean
absorbency in control wells) × 100.
2.4. Enzyme-Linked Immunosorbent Assay (ELISA). The
HaCaT cells (1×106/well) were seeded into 6-well plates in
1mL medium with 10% FBS. After reaching conﬂuence,
the cells were washed and incubated with 1mL serum-
free medium containing the indicated concentration of
IFN-γ for 24h. The culture supernatants were analyzed for
TARC and MDC by ELISA (R&D Systems) according to
the manufacturer’s instructions. In some experiments, the
HaCaT cells were incubated with BCL or pharmacological
inhibitors together with IFN-γ.
2.5. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Total RNA was isolated by using the TRI reagent
(Molecular Research Center Inc., Cincinnati, USA). The
quantity and purity of RNA were veriﬁed by measuring A260
and A280. cDNA was synthesized from total RNA (2μg)
a n do l i g od( T ) 18 primers (0.5μg) using Prime RT Premix
kit (GeNet Bio, Korea) according to the manufacturer’s ins-
tructions. The cDNA obtained was then ampliﬁed using
Prime Taq Premix kit (GeNet Bio, Korea) following the man-
ufacturer’s instruction. The primers used in this study were
as follows: TARC (forward) 5 -ATG GCC CCA CTG AAG
ATG CT-3 ,(reverse)5  -TGA ACA CCA ACG GTG GAG GT-
3 ; MDC (forward) 5 -AGG ACA GAG CAT GGC TCG CCT
ACA GA-3 ,( r e v e r s e )5  -TAA TGG CAG GGA GGT AGG
GCT CCT GA-3 ; and GAPDH (forward) 5 -ACC ACA GTC
CAT GCC ATC AC-3 ,( r e v e r s e )5  -TCC ACC ACC CTG
TTG CTG TA-3 . GAPDH primers were used as an internal
control. All mixtures were denatured at 94◦C for 5min.
Conditions of PCR ampliﬁcation were as follows: TARC,
94◦C for 30s, 62◦C for 30s, and 72◦C for 30s for a total
of 30 cycles; MDC, 94◦C for 30s, 65◦C for 30s, and 72◦C
for 30s for a total of 32 cycles; GAPDH, 94◦C for 30s, 56◦C
for 30s, and 72◦C for 30s for a total of 30 cycles. Following
these cycles of PCR ampliﬁcations, the ampliﬁed cDNAs
were further extended by an additional extension at 72◦Cf o r
7min. Ampliﬁed products were subjected to electrophoresis
on 2% agarose gels and visualized by staining with ethidium
bromide.
2.6. Whole-Cell and Nuclear Fractionation. The preparation
of whole-cell and nuclear extracts were performed usingEvidence-Based Complementary and Alternative Medicine 3
a Nuclear Extract Kit (Active Motif, Carlsbad, Calif, USA).
Brieﬂy, HaCaT cells (2 × 107) were washed twice with
3mL ice-cold PBS (phosphate buﬀered solution) containing
phosphatase inhibitors, centrifuged 5min at 500×ga t4 ◦C,
lysed in 300μL Complete Lysis Buﬀer, mixed completely
and centrifuged at 14000×gf o r2 0m i na t4 ◦C, supernatant
(whole-cell extract) were then stored at −80◦C until further
use. For the nuclear extracts, after washing, cells were
lysed in 500μL hypotonic buﬀer and then centrifuged at
14000×gf o r3 0sa t4 ◦C. After removing the supernatant,
p e l l e t sw e r er e s u s p e n d e di n5 0μL complete lysis buﬀer and
centrifuged at 14000×gf o r1 0 m i na t4 ◦C. Supernatants
(nuclear fraction) were then stored at −80◦C until further
use. Protein concentrations were determined using the Bio-
Rad Protein Assay (Bio-Rad Laboratories, Calif, USA).
2.7. Western Blotting Analysis. HaCaT cells were treated with
medium alone or with IFN-γ in the presence or absence
of drugs for the indicated time. Proteins (30μg) were
separated on SDS-PAGE and transferred onto nitrocellulose
membranes. Membranes were then blocked with 5% nonfat
milk, washed brieﬂy, incubated with primary antibodies at
4◦Covernight,andthenincubatedwithcorrespondingHRP-
conjugated secondary antibodies for 1h at room temper-
ature. Protein bands were visualized by incubating mem-
branes with chemiluminescence reagents before exposure
to X-ray ﬁlm. The quantitation of the chemiluminescent
signal was analyzed using Image-Pro Plus version 6.0 (Media
Cybernetics, Md, USA).
2.8. Determination of ROS Generation. The level of intra-
cellular ROS was assessed by measuring the oxidation of
2 ,7 -dichlorodihydroﬂuorescin diacetate (DCFH-DA) using
DTX-880 multimode microplate reader (Beckman Coulter
Inc., Fullerton, Calif, USA) and ﬂuorescence microscopy
(Olympus, Japan) as described previously [18].
2.9. Immunocytochemistry. Immunocytochemistry was per-
formed as described previously [18]. In brief, cells incubated
on BD FalconTM culture slides (BD Biosciences, Bedford,
Mass, USA) were ﬁxed with 3.7% formaldehyde and per-
meabilized with 0.5% Triton X-100. Slides were washed
with PBS, blocked for one hour with 3% bovine serum
albumin, and incubated with rabbit monoclonal anti-NF-
κB p65 antibody (1:50) overnight at 4◦C. The cells were
then washed and incubated with Alexa Fluor 488 goat anti-
rabbitIgG(H+L)(1:200)foronehouratroomtemperature,
and nuclei were stained for 10min with DAPI (10μg/mL).
The stained cells were mounted with mounting medium and
observed by Leica DMI 4000 confocal microscope (Leica,
Wetzlar, Germany).
2.10. Statistical Analysis. All data are presented as the mean
± SEM of at least three separate experiments. Statistical
analysis was performed using one-way ANOVA followed by
Dunnett’s multiple comparison test. A P value of less than
0.05 was considered to be statistically signiﬁcant.
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Figure 1: Eﬀect of BCL (Bambusae caulis in Liquamen) on the
viability of HaCaT cells. All values are presented as mean ± SEM of
three experiments conducted in duplicate. ∗P<0.05 versus control
cells incubated with media alone.
3. Results
3.1. Cell Viability. As shown in Figure 1, BCL at 0–2%
(v/v) had a minimal eﬀect on the viability of HaCaT cells,
although it signiﬁcantly reduced the viability at the higher
concentration of 2.5% after 24h incubation. Therefore, 2%
was determined as the maximum concentration of BCL for
use throughout the following experiments.
3.2. BCL Inhibits IFN-γ-Induced Expression of TARC and
MDC in HaCaT Cells. BCL (0.5%–2%) suppressed IFN-
γ-stimulated TARC release in a dose-dependent manner
(Figure 2(a)). IFN-γ greatly induced TARC release (326.6
± 11.20pg/mL) from HaCaT cells, and this release was
reduced to 235.3 ± 6.948pg/mL (P<0.01) and 198.2 ±
4.977pg/mL (P<0.001) by treatment of BCL at 1% and 2%,
respectively. Similarly, BCL dose-dependently suppressed
IFN-γ-stimulated mRNA expression of TARC (Figure 2(b)).
In a way similar to TARC, MDC expression was signiﬁcantly
suppressed at both transcriptional and posttranscriptional
levels with the treatment of BCL (Figures 2(c) and 2(d)).
3.3. BCL Inhibits the Activation of NF-κBb u tN o tp 3 8M A P K
in HaCat Cells. The activation of p38 MAPK results in phos-
phorylation at threonine and tyrosine residues of this kinase
[20]. In this study, the phosphorylation of p38 MAPK
was induced following 30min incubation with IFN-γ
(10ng/mL), and this phosphorylation was not aﬀected by
BCL (2%) treatment. However, the speciﬁc inhibitor of p38
MAPK, SB203580, signiﬁcantly suppressed the phosphoryla-
tion of p38 MAPK (Figure 3(a)).
On the other hand, the p65 subunit is the primary
component of activated NF-κB, the activation of NF-κBi n
IFN-γ-stimulated HaCaT cells was studied by measuring
the nuclear translocation of NF-κB subunit p65 by Western
blot. IFN-γ signiﬁcantly increased the nuclear translocation
of NF-κB p65 at 30min. BCL (2%) decreased the nuclear
levels of NF-κB p65 by approximately 60% in IFN-γ-
stimulated HaCaT cells (P<0.01) (Figure 3(b)), strongly4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀe c t so fB C Lo nI F N - γ-induced production of thymus and activation-regulated chemokine (TARC) and macrophage-derived
chemokine (MDC) in HaCaT cells. (a) and (b) BCL (0.5%–2%) suppressed IFN-γ-stimulated TARC release in a dose-dependent manner.
(c) and (d) MDC expression was signiﬁcantly suppressed at both transcriptional and posttranscriptional levels with the treatment of BCL
Data are presented as mean ± SEM of three experiments conducted in duplicate. ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 versus IFN-γ.
suggesting that BCL can inhibit the activation of NF-κBi n
HaCaT cells. In a manner similar to BCL, the NF-κB in-
hibitor, Bay11-7082, suppressed IFN-γ-induced nuclear
translocation of NF-κB by approximately 85% (Figure 3(b)).
Furthermore, the inhibitory eﬀect of BCL on IFN-γ-induced
nuclear translocation of NF-κB p65 was also observed using
immunocytochemistry analysis (Figure 3(c)). Collectively,
these ﬁndings strongly suggest that BCL can inhibit the acti-
vation of NF-κB in HaCaT cells.
3.4. BCL Blocked the Degradation and Phosphorylation of IκB
in HaCaT Cells. In our Western blotting results, BCL (2%)
markedly blocked IFN-γ-(10ng/mL)induced degradation of
IκB-α (P<0.01) (Figure 3(d)). In addition, IFN-γ-induced
phosphorylation of IκB-α was also signiﬁcantly suppressed
by the addition of 2% BCL (P<0.05) (Figure 3(e)).
Taken together, BCL could suppress the activation of NF-
κB through IκB-α signaling but not through p38 MAPK
signaling in HaCaT cells.
3.5. Determination of Antioxidant Eﬀects of BCL. Intracel-
lular ROS generation contributes to the production of Th2
chemokines by increasing activation of IkB/NF-κBp a t h w a y s
[18]. As the results of DCFH-DA analysis and DPPH analysisEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: BCL suppressed the activation of NF-κB via IκB but not via p38 pathway. The phosphorylation of p38 MAPK induced after
incubation with IFN-γ was not aﬀected by BCL (2%) treatment. Phosphorylation of p38 MAPK was signiﬁcantly suppressed by SB203580.
(b) IFN-γ signiﬁcantly increased the nuclear translocation of NF-κB p65, but BCL (2%) decreased the nuclear levels of NF-κBp 6 5b ya b o u t
60% in IFN-γ-stimulated HaCaT cells. NF-κB inhibitor, Bay11-7082, suppressed IFN-γ-induced nuclear translocation of NF-κBb ya b o u t
85%. (c) The inhibitory eﬀect of BCL on IFN-γ-induced nuclear translocation of NF-κB p65 was observed using immunocytochemistry
analysis. (d) BCL (2%) markedly blocked IFN-γ- (10ng/mL)induced degradation of IκB-α.( e )I F N - γ-induced phosphorylation of IκB-
α was also signiﬁcantly suppressed by the addition of 2% BCL. All of data are presented as mean ± SEM of three separate experiments.
∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 versus IFN-γ alone.
using BCL, both ROS generation induced by IFN-γ or
H2O2 was signiﬁcantly blocked by the addition of BCL
(P<0.01 and P<0.001, resp.) (Figure 4(a)). More-
over, typical green ﬂuorescence indicative of the generation
of ROS was also observed under the ﬂuorescence microscope
(Ex = 488nm, Em = 525nm, Olympus) (Figure 4(b)), indi-
cating that BCL possesses the ability to scavenge ROS in
human keratinocytes. In addition, DPPH analysis showed
that DPPH free radicals could be signiﬁcantly scavenged
both in dose- and time-dependent manners (Figures 4(c)6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Antioxidant eﬀects of BCL. (a) ROS generation induced by IFN-γ or H2O2 were signiﬁcantly blocked by the addition of BCL. (b)
Typical images of ROS generation (green ﬂuorescence) under the ﬂuorescence microscope (100x). (c) and (d) DPPH free radicals could be
signiﬁcantly scavenged both in dose- and time-dependent manners. Data are presented as the mean ± SEM of three separate experiments
conducted in duplicate. ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 versus control.
and 4(d)). These results strongly suggest that BCL possesses
antioxidant eﬀects, thereby suppressing the production of
Th2 chemokines via blocking ROS/IκB/NF-κBp a t h w a y si n
HaCaT cells.
4. Discussion
In the present study, we investigated the in vitro eﬀects of
BCL on Th2-type immune response using HaCaT cells, an
in vitro model of atopic dermatitis [21]. Our results clearly
showed that BCL suppressed the expression of TARC and
MDC in HaCaT cells, which strongly indicates that BCL
might be used clinically as a potential therapeutic agent for
atopic dermatitis.
Atopic dermatitis is a Th2-type skin disease in which the
inﬂammation is characterized by the inﬁltration of lympho-
cytes into a dermis. TARC is one of the functional ligands
for CCR4 which is preferentially expressed on Th2-type cells,
and chemoattracts the CCR4-Th2-type cells into lesional
sites in skin [8, 9]. Previous studies have demonstrated that
TARC is highly expressed in a basal epidermis of lesional
skin in NC/Nga mice [5] and in diﬀerent layers of lesional
epidermis from patients with AD but not in the nonlesional
skin [11]. MDC is another important chemokine for lym-
phocytes inﬁltration in inﬂammatory sites, and its receptor
is CCR4 as TARC. High level of MDC was observed in
the monocyte-derived dendritic cells (MoDCs) isolated from
venous blood in patients with AD [22] and in keratinocytes
in lesional skin of atopic dermatitis [23]. Taken together,
the levels of TARC and MDC were signiﬁcantly higher in
AD patients compared with the healthy control subjects
[10]. These preclinical and clinical studies suggest that TARC
and MDC are major molecules which are involved in theEvidence-Based Complementary and Alternative Medicine 7
pathogenesis of AD. Interestingly, our results show that BCL
suppresses IFN-γ-induced expression of TARC and MDC in
human HaCaT keratinocytes, indicating that BCL possesses
immunosuppressive properties. This hypothesis is consistent
with previous studies showing that BCL suppressed the
expression of diﬀerent CD (cluster of diﬀerentiation) genes
in human mast cells [14] and that BCL is used as a folk
medicine for skin diseases, including eczema and atopic
dermatitis [16]. Furthermore, BCL inhibits the development
of DNCB-induced AD-like skin lesions in hairless mice by
suppressing Th2 immune response [17].
Previousstudieshavedemonstratedthatseveralsignaling
molecules such as JAKs, MAPKs, STAT, or NF-κB are in-
volved in the regulation of immune responses depending on
the cell type [24–27]. Furthermore, both promoters of TARC
and MDC contain STAT- and NF-κB-binding sites [26],
and the transcriptional activities of STAT1 and NF-κBa r e
increased in keratinocytes with treatment of IFN-γ [28], so
these transcription factors may be involved in the mediation
of these two chemokines. Our recent study found that both
p38 MAPK and ROS signaling contribute the activation
of NF-κBp a t h w a y ,r e s p e c t i v e l y[ 18]. Although p38 MAPK
contributes to the activation of NF-κB in keratinocytes
[25, 29], the present study showed that BCL signiﬁcantly
suppressed the nuclear translocation of NF-κB, but not
phosphorylation of p38 MAPK, suggesting that BCL inhibits
the activation of NF-κB but not that of p38 MAPK. This idea
is further supported by several previous studies showing that
certainbambooextractsinhibitIL-12inmousemacrophages
via suppression of NF-κB inﬂammatory signaling pathway
[30] and that certain herbal extracts such as polyphenols
and polysaccharides possess immune-regulating or anti-
inﬂammatory properties [31, 32].
Reactive oxygen species (ROS) is one of the important
biomarkers of oxidative stress, and it can function as se-
cond messengers during inﬂammatory signaling [33]a n d
contribute to proinﬂammatory eﬀects and nuclear factor-κB
activation in immune cells [34] and keratinocytes [18]. IFN-
γ has been shown to increase ROS generation in cultured
human retinal pigment epithelial (RPE) cells [35], mouse
primary hepatocytes [36], mouse biliary epithelial cells
(BECs) [37], human endothelial cells [38], and human ker-
atinocytes [18]. Taken together, these previous data suggest
that intracellular ROS levels are intimately associated with
the development of inﬂammation dependent on cell types.
BCL is the nutritious liquid isolated from fresh bamboo
stems which contain various biologically active components,
such as ﬂavonoid, phenolic compounds, polyphenolic com-
pounds, chlorogenic acid derivatives, and various organic
acids. Many of these ingredients have been reported to have
antioxidant eﬀect [15, 16, 39, 40]. As expected, we directly
demonstrated the antioxidant activity of BCL in this study,
indicating that the antioxidant activity of BCL contributes
to the inhibition of NF-κB and thereby suppresses the
production of TARC and MDC in human keratinocytes.
In conclusion, BCL signiﬁcantly suppressed IFN-γ-
induced expression of TARC and MDC by inhibiting the
activation of ROS/IκB/NF-κB pathways, in a p38 MAPK-in-
dependent manner in HaCaT cells. These results are sup-
posed to be due, at least in part, to its antioxidant eﬀects.
The blocking of Th2 chemokines by BCL may suppress the
inﬁltration of Th2 cells and lessen inﬂammation of skin
lesions. It suggests that BCL may have a therapeutic potential
on skin disease such as atopic dermatitis by inhibiting Th2
chemokines, which is due, at least in part, to its antioxidant
capacities.
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